The WIRED article explores the potential of fecal microbiota transplants (FMT) in treating gut-related diseases by restoring healthy bacteria. It discusses the challenges of finding suitable donor stool and proposes the concept of autologous transplants—using one's own stored fecal matter for future treatments. This approach could mitigate issues related to donor compatibility and disease transmission. While FMT has shown success in treating conditions like Clostridioides difficile infections, its application in neurological conditions such as Parkinson's disease and multiple sclerosis is still under investigation. Maintaining a healthy gut microbiome through a balanced diet rich in fiber and fermented foods may support overall brain health. However, the efficacy of FMT for cognitive enhancement remains unproven, and more research is needed to establish its safety and effectiveness in this context.